SS 34 - GYN 2: Strategies and Innovations of Clinical Trials in Gynecologic Cancers

Moderator(s)

• 

  Sudha Amarnath, MD

  Cleveland Clinic Taussig Cancer Center
  Cleveland, Ohio, United States
• KR

  Kara Romano, MD

  University of Virginia
  Charlottesville, Virginia

Presentations:

• 2:30 PM – 2:40 PM ET

  Induction Chemotherapy plus Concurrent Chemoradiotherapy vs. Concurrent Chemoradiotherapy Alone in High-Risk Locally Advanced Cervical Carcinoma: A Phase 2, Multicenter, Randomized Controlled Trial
  

  Presenter: Hua Yang, MD – The First Affiliated Hospital of Air Force Medical University
• 2:40 PM – 2:50 PM ET

  Comparison of Image-Guided Intensity Modulated Radiotherapy (IG-IMRT) vs. Conventional Radiotherapy (4FRT) for Locoregionally Advanced Cervical Cancer on the NRG GY006 Trial
  

  Presenter: Loren Mell, MD, FASTRO – University of California, San Diego
• 2:50 PM – 3:00 PM ET

  IMMUNOCERV Phase II Trial Combining the HPV-Specific T Cell Immunotherapy PDS0101 with Chemoradiation for Treatment of Locally Advanced Cervical Cancer
  

  Presenter: Adam Grippin, MD, PhD – MD Anderson Cancer Center
• 3:00 PM – 3:10 PM ET

  Influence of Cachexia in Locally Advanced Endometrial Cancer: A Secondary Analysis of NRG GOG 258/RTOG 1203
  

  Presenter: Eric Donnelly, MD – Northwestern Memorial Hospital
• 3:10 PM – 3:20 PM ET

  Comparison of Docetaxel and Cisplatin Concurrent and Short-Course Adjuvant Chemotherapy with Cisplatin Concurrent Chemotherapy in Radiotherapy for Locally Advanced Cervical Cancer: A Phase III Multice
  

  Presenter: Ying Zhang
• 3:20 PM – 3:30 PM ET

  Five-Year Outcomes of a Phase II Study of Post-Operative Proton Beam Radiation for Gynecologic Cancers
  

  Presenter: Andrea Russo, MD – Massachusetts General Hospital
• 3:30 PM – 3:40 PM ET

  Discussant
  

  Discussant: Kristin Bradley, MD – University of Wisconsin